E7727
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for E7727, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors [Phase 1]